πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

1,254 results for β€œFirst” Clear

  1. Anti-CD19 CAR-T

    First Tracks Biotherapeutics

    Acute Lymphoblastic Leukemia ,Lymphomas

    phase 2 mab active

    1 trial

  2. Anti-PD-1 antibody

    First Tracks Biotherapeutics

    Chronic Hepatitis b

    phase 2 small molecule active

    1 trial

  3. Apatinib

    First Tracks Biotherapeutics

    Advanced Esophageal Squamous Carcinoma

    phase 2 small molecule active

    1 trial

  4. Apatinib

    First Tracks Biotherapeutics

    Systematic Review of the pCR Rate of Apatinib Combined With Albumin Paclitaxel and Carboplatin Regimen for Neoadjuvant Therapy of Triple-negative Breast Cancer

    phase 2 small molecule active

    1 trial

  5. Apatinib

    First Tracks Biotherapeutics

    Advanced Solid Tumors

    phase 2 small molecule active

    1 trial

  6. Apatinib

    First Tracks Biotherapeutics

    Lung Cancer

    phase 2 small molecule active

    1 trial

  7. Apatinib

    First Tracks Biotherapeutics

    Intrahepatic Cholangiocarcinoma

    phase 2 small molecule active

    1 trial

  8. Apatinib

    First Tracks Biotherapeutics

    Malignant Ascites

    phase 2 small molecule active

    1 trial

  9. Apatinib

    First Tracks Biotherapeutics

    Breast Cancer

    phase 2 small molecule completed

    1 trial

  10. Apatinib

    First Tracks Biotherapeutics

    Non Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  11. Apatinib

    First Tracks Biotherapeutics

    Thyroid

    phase 2 small molecule active

    1 trial

  12. Apatinib Combined With SHR-1210 Injection

    First Tracks Biotherapeutics

    Hepatocellular Carcinoma

    phase 2 small molecule active

    1 trial

  13. Apatinib mesylate tablets

    First Tracks Biotherapeutics

    Gastric Cancer

    phase 2 small molecule active

    1 trial

  14. Apatinib+ SHR-1210（CamrelizumabοΌ‰

    First Tracks Biotherapeutics

    Esophageal Cancer

    phase 2 small molecule active

    1 trial

  15. Apheresis and Bridging Therapy

    First Tracks Biotherapeutics

    Large B-cell Lymphoma

    phase 2 other completed

    1 trial

  16. Ara-C Group

    First Tracks Biotherapeutics

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  17. Arm 1： Standard Synchronous Group

    First Tracks Biotherapeutics

    Advanced Non-Small Cell Lung Cancer (NSCLC)

    phase 2 small molecule active

    1 trial

  18. Arm A

    First Tracks Biotherapeutics

    Esophageal Cancer

    phase 2 small molecule active

    1 trial

  19. Atorvastatin

    First Tracks Biotherapeutics

    Myocardial Infarction

    phase 2 small molecule active

    1 trial

  20. Aumolertinib

    First Tracks Biotherapeutics

    Lung Cancer

    phase 2 small molecule active

    1 trial

  21. Autologous CD5 CAR T-cells

    First Tracks Biotherapeutics

    T-Cell Acute Lymphocytic Leukemia

    phase 2 small molecule active

    1 trial

  22. Azacitidine

    First Tracks Biotherapeutics

    Philadelphia Chromosome

    phase 2 small molecule completed

    1 trial

  23. Azacitidine (AZA) with Ruxolitinib

    First Tracks Biotherapeutics

    MDS/MPN

    phase 2 small molecule active

    1 trial

  24. Azacitidine Injection

    First Tracks Biotherapeutics

    B Acute Lymphoblastic Leukemia

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources